Adamax nasal spray reconstitution: what the science says
Quick answer
Adamax is a branded peptide blend based on Semax, a synthetic analog of the ACTH(4-7) fragment studied primarily in Russian clinical literature for neuroprotective and cognitive effects via BDNF and NGF upregulation. Intranasal delivery is pharmacologically plausible for CNS exposure, but the product is not FDA-approved, is sourced from a research chemical vendor, and its purity and composition cannot be verified by consumers. The creator's stated intent to use it to recover from a head injury is not supported by human clinical trial evidence for acute traumatic brain injury.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @nickmfballard actually say?
Nick walked viewers through a step-by-step reconstitution of a 5mg vial of Adamax, a branded peptide blend containing Semax, into a nasal spray. He used 1mL of saline to dissolve the peptide, then added 2mL more saline to a spray bottle, transferred the reconstituted peptide, and calculated that each 0.12mL actuation would deliver approximately 200 micrograms. He specifically chose saline over bacteriostatic water, noting that bacteriostatic water "is going to irritate your nose." He also mentioned wanting to "rebuild my brain tissue" after apparently sustaining a head injury. He sourced the product from a research chemical vendor and promoted a discount code.
Does the science back this up?
The math checks out, and the saline preference for nasal delivery is reasonable, but the brain tissue claim is where things go off the rails. Semax, the core active in Adamax, does have legitimate preclinical and some clinical data, mostly from Russian research, but claims about tissue rebuilding in humans after acute head trauma are not supported by robust evidence.
Semax is a synthetic heptapeptide analog of ACTH(4-7) that has been studied for neuroprotective and nootropic effects. Russian clinical trials, including work by Shadrina et al. (2010, Molecular Biology), showed increased BDNF and NGF expression with Semax administration, which is genuinely interesting. A small Russian study (Miasoedov et al., 1999, Zhurnal Nevrologii) examined intranasal Semax in ischemic stroke patients and reported some functional improvements. However, these are small, older, mostly non-Western studies that have not been replicated in large randomized controlled trials. The leap from "may support neurotrophin expression" to "rebuild my brain tissue" after a fall is not supported by available evidence.
What did they get right and wrong?
Credit where it is due: the reconstitution technique itself is reasonable. Wiping down vials with alcohol, using sterile saline for nasal delivery instead of bacteriostatic water, and the dosing arithmetic are all defensible practice for someone handling research peptides. Bacteriostatic water contains 0.9% benzyl alcohol, and that concentration in a nasal spray would genuinely cause irritation. Saline is the correct choice here.
What he got wrong, or at least badly oversimplified:
- Calling this product "Adamax" throughout while mispronouncing it as "Atomax" creates confusion about what is actually in the vial. Adamax is a branded blend, and its exact composition and purity from a research chemical vendor cannot be independently verified by the viewer.
- The claim that he plans to use this to "rebuild my brain tissue" after a head injury is not a proven therapeutic use. This is the kind of claim that gives peptide content a bad reputation. It is not backed by human clinical trial evidence for acute traumatic brain injury.
- He is sourcing from a research chemical company and promoting it with a discount code. This product is not FDA-approved for human use, and that fact is never mentioned.
What should you actually know?
Semax has one of the more interesting research profiles in the peptide space, but most of that research comes from Soviet-era and post-Soviet Russian science, which has real methodological limitations and limited independent replication. That does not mean it is useless, but it means the confidence level should be modest, not enthusiastic.
Intranasal delivery of peptides is pharmacologically sensible. The nasal mucosa offers direct access to the olfactory epithelium, which has a pathway to the central nervous system that bypasses the blood-brain barrier to some degree. This is part of why intranasal routes are studied for CNS-active compounds. The 200mcg per actuation dose Nick calculated is within the range used in some research protocols, but dosing from a TikTok video for a head injury is not a substitute for clinical evaluation.
Anyone watching this should know: this product is sold as a research chemical, not a medicine. Using it for a self-diagnosed neurological injury without medical supervision is a meaningful risk, not a wellness optimization hack.
The regulatory reality
Adamax, Semax, and related peptides are not FDA-approved drugs in the United States. They are sold by research chemical vendors under the legal fiction that they are for laboratory use only. Purchasing, reconstituting, and self-administering these compounds occupies a legal gray area that varies by jurisdiction. The vendor promotion at the end of the video, complete with a discount code, makes this content function as advertising for an unapproved substance. Viewers deserve to know that context before following along.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 5 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Adamax nasal spray reconstitution: what the science says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Functional Connectomic Approach to Studying Selank and Semax Effects
Small Russian fMRI study (52 healthy volunteers) of brain connectivity after Semax or Selank; mechanistic and exploratory, not a clinical efficacy trial.
PubMed
Effects of Semax on the Default Mode Network of the Brain
Small human fMRI study (24 adults) of intranasal Semax on brain networks; an imaging-marker study with no clinical outcomes, not replicated outside the originating group.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Adamax nasal spray reconstitution: what the science says is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Helpful context before the funnel
Claim verdict
The useful answer behind this video
Claim being checked
Adamax is a branded peptide blend based on Semax, a synthetic analog of the ACTH(4-7) fragment studied primarily in Russian clinical literature for neuroprotective and cognitive effects via BDNF and NGF upregulation.
FormBlends verdict
Adamax is a branded peptide blend based on Semax, a synthetic analog of the ACTH(4-7) fragment studied primarily in Russian clinical literature for neuroprotective and cognitive effects via BDNF and NGF upregulation. Intranasal delivery is pharmacologically plausible for CNS exposure, but the product is not FDA-approved, is sourced from a research chemical vendor, and its purity and composition cannot be verified by consumers. The creator's stated intent to use it to recover from a head injury is not supported by human clinical trial evidence for acute traumatic brain injury.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Adamax is a branded peptide blend based on Semax, a synthetic analog of the ACTH(4-7) fragment studied primarily in Russian clinical literature for neuroprotective and cognitive effects via BDNF and NGF upregulation. Intranasal delivery is pharmacologically plausible for CNS exposure, but the product is not FDA-approved, is sourced from a research chemical vendor, and its purity and composition cannot be verified by consumers. The creator's stated intent to use it to recover from a head injury is not supported by human clinical trial evidence for acute traumatic brain injury.
- Semax, the active compound in Adamax, has the most clinical data from Russian studies including Miasoedov et al. (1999) in stroke patients, but these are small, older trials not replicated in large Western RCTs.
- Saline is the correct choice over bacteriostatic water for nasal sprays because benzyl alcohol, the preservative in bacteriostatic water, is a nasal irritant.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Semax, the active compound in Adamax, has the most clinical data from Russian studies including Miasoedov et al. (1999) in stroke patients, but these are small, older trials not replicated in large Western RCTs.
- Saline is the correct choice over bacteriostatic water for nasal sprays because benzyl alcohol, the preservative in bacteriostatic water, is a nasal irritant.
- The dosing math in the video is accurate: 5mg in 3mL total volume at 0.12mL per actuation does equal approximately 200mcg per spray.
- Intranasal delivery is pharmacologically rational for CNS-targeting peptides because the olfactory epithelium provides a partial route that bypasses the blood-brain barrier, but this does not validate the specific health claims made.
- Adamax is not FDA-approved for human use. It is sold as a research chemical, and its purity and composition from third-party vendors cannot be independently verified by consumers.
- The claim that Semax can rebuild brain tissue after a traumatic head injury is not supported by human clinical evidence and should not be treated as a substitute for medical evaluation after a head injury.
- Shadrina et al. (2010, Molecular Biology) documented BDNF and NGF upregulation with Semax in animal and limited human models, which is the legitimate scientific basis for interest in the compound, not tissue reconstruction claims.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
nickmfballard · TikTok creator
40.4K views on this video
How to reconstitute Adamax into a nasal spray #adamax #limitless #reconstitution #semax #peptide
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by nickmfballard, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.